Home > Boards > US Listed > Medical - Drugs >

Esperion Therapeutics (ESPR)

ESPR RSS Feed
Add ESPR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/7/2019 8:01:31 AM - Followers: 20 - Board type: Free - Posts Today: 0

Esperion is a biopharmaceutical company focused on the research, development and commercialization of potential therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors. Many patients with elevated risk of heart disease are unable to benefit from statins, the current leading treatments, due to the side effects caused by these therapies. Our lead product candidate, ETC-1002, is a first-in-class orally available small molecule designed to significantly lower elevated levels of LDL-C and improve other cardiometabolic risk factors — without the side effects associated with statin use.
ESPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ESPR News: Esperion to Participate in Upcoming Investor Conferences 05/10/2019 08:00:00 AM
ESPR News: Quarterly Report (10-q) 05/08/2019 04:37:18 PM
ESPR News: Current Report Filing (8-k) 05/08/2019 08:02:17 AM
ESPR News: Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports First Quarter Financial Results 05/08/2019 07:00:00 AM
ESPR News: Esperion to Host Analyst and Investor Day Event on May 30 05/07/2019 05:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#219   News: $ESPR Esperion to Host Analyst and Investor whytestocks 05/07/19 08:01:31 AM
#218   Good news. Buying more and holding. https://globenewswire.com/news-release/201 drusso12345 05/06/19 07:23:06 AM
#217   Perhaps buried somewhere in the media stories is north40000 03/16/19 09:05:46 AM
#216   News: $ESPR Bempedoic Acid Study 1 Results Published whytestocks 03/14/19 09:00:40 AM
#215   https://www.nbcnews.com/health/heart-health/new-cholesterol-lowering-drug-could- drusso12345 03/13/19 08:47:26 PM
#214   Odd announcing 2 NDA's and EU submission. Usually, Johnny_C 03/03/19 11:41:45 PM
#213   Looks like we went to 40 first, great buy! Johnny_C 01/07/19 11:46:57 AM
#212   I think back to 80 Johnny_C 11/01/18 12:30:41 PM
#211   My wife works for big Pharma, pretty high Johnny_C 08/29/18 12:08:33 PM
#210   80% with recent large insider purchase. Fingers crossed. BuckeyeMike 08/19/18 10:19:39 PM
#209   What odds do you place on the safety faxedreceipts 08/19/18 09:07:53 PM
#208   Congrats and I agree. All Phase I, BuckeyeMike 08/19/18 06:08:42 PM
#207   yup...went all in at 37 and 38. Good Johnny_C 08/18/18 05:26:46 AM
#206   Pretty sure they have two Phase 3 results BuckeyeMike 08/08/18 10:28:59 AM
#205   I still am surprised such a big drop, Johnny_C 08/08/18 10:11:00 AM
#204   Over 6 Mil shares short w/ volume drying BuckeyeMike 08/08/18 09:54:51 AM
#203   Good chance this will see the 80’s again. Johnny_C 07/24/18 07:07:04 AM
#202   This drop is very strange, 1 bil market Johnny_C 05/23/18 06:31:43 PM
#201   Ameritrade shows Tutes own 103.7% of the float BuckeyeMike 05/16/18 08:56:25 PM
#200   13G 's last 7 days show accumulation by jdlamont 05/16/18 07:08:37 PM
#199   Good to hear! Looking forward to BuckeyeMike 05/16/18 05:47:10 PM
#198   Company speaking today after close, should be good jdlamont 05/15/18 02:19:40 PM
#197   Agreed. Bullish on ESPR BuckeyeMike 05/10/18 11:02:37 PM
#196   nothing has changed but the stock price. Hype jdlamont 05/04/18 09:29:18 AM
#195   Did not hold $50. Grandmasters 05/03/18 11:21:41 AM
#194   Current $54.00 Grandmasters 05/02/18 10:12:06 AM
#193   Looking for a good entry! Grandmasters 05/02/18 10:06:16 AM
#192   ESPR slides from phase-3-results CC: DewDiligence 03/07/18 03:36:46 PM
#191   ESPR buy 71.7441 stocktrademan 03/07/18 01:45:44 PM
#190   Yep :-) BuckeyeMike 12/24/17 06:41:22 PM
#189   Didn’t PFE buy his first Esperian. This Johnny_C 12/21/17 09:40:29 AM
#188   Took a while, but finally in at 30 Johnny_C 12/21/17 09:39:01 AM
#187   Nearly 102% owned by Institutions. Key take BuckeyeMike 11/20/17 10:34:55 AM
#186   With that pipeline drop, what might MRK become north40000 10/14/17 05:30:23 PM
#185   Merck announced after hours yesterday it will not BuckeyeMike 10/12/17 09:44:04 AM
#184   https://seekingalpha.com/article/4096984-esperions-triple-combo-hits-home-run Inoviorulez 08/09/17 05:26:59 PM
#183   Chart looking decent.... MACD upswing... BuckeyeMike 06/06/17 09:35:34 PM
#182   Another solid day on $ESPR TurboStocks 05/16/17 05:46:38 PM
#181   ESPR bullish 39.03 stocktrademan 04/14/17 06:22:47 PM
#180   Comments?: north40000 04/14/17 12:35:53 PM
#179   Bempedoic Acid also lowers inflammation which could be BuckeyeMike 04/10/17 11:25:03 PM
#178   This big picture is the statins are now Stockstuffer83 04/10/17 01:17:57 PM
#177   You took a while to show up with north40000 04/06/17 11:53:33 AM
#176   Vascepa is fancy fish oil. This drug is Stockstuffer83 04/06/17 11:22:13 AM
#175   Keep on radar may see a squeeze very soon PLelek 03/29/17 08:02:33 PM
#174   Boxer Capital, LLC has filed a new 13G, wiltonio 03/23/17 04:42:00 PM
#173   I posed the following rhetorical question last Sunday, north40000 03/22/17 03:01:45 PM
#172   Read results, conclusions and discussion sections from the following: north40000 03/22/17 08:31:28 AM
#171   $48.21 today. WOW, simply amazing STOCK_MOMO 03/21/17 10:27:50 AM
#170   Time to load the $41s stopped making new runningwithscissors 03/21/17 10:19:31 AM
PostSubject